<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
<headerData>
<submissionType>SCHEDULE 13G/A</submissionType>
<previousAccessionNumber>0000929638-24-003817</previousAccessionNumber>
<filerInfo>
<filer>
<filerCredentials>
<cik>0001408970</cik>
<ccc>XXXXXXXX</ccc>
</filerCredentials>
</filer>
<liveTestFlag>LIVE</liveTestFlag>



</filerInfo>
</headerData>
<formData>
<coverPageHeader>
<amendmentNo>1</amendmentNo>
<securitiesClassTitle>Common Shares, no par value</securitiesClassTitle>
<eventDateRequiresFilingThisStatement>03/31/2025</eventDateRequiresFilingThisStatement>
<issuerInfo>
<issuerCik>0001728328</issuerCik>
<issuerName>InMed Pharmaceuticals Inc.</issuerName>
<issuerCusip>457637601</issuerCusip>
<issuerPrincipalExecutiveOfficeAddress>
<com:street1>Suite 1445 - 885 W. Georgia Street</com:street1>
<com:city>Vancouver</com:city>
<com:stateOrCountry>A1</com:stateOrCountry>
<com:zipCode>00000</com:zipCode>
</issuerPrincipalExecutiveOfficeAddress>
</issuerInfo>
<designateRulesPursuantThisScheduleFiled>
<designateRulePursuantThisScheduleFiled>Rule 13d-1(b)</designateRulePursuantThisScheduleFiled>
</designateRulesPursuantThisScheduleFiled>
</coverPageHeader>
<coverPageHeaderReportingPersonDetails>

<reportingPersonName>AdvisorShares Trust</reportingPersonName>
<citizenshipOrOrganization>DE</citizenshipOrOrganization>
<reportingPersonBeneficiallyOwnedNumberOfShares>
<soleVotingPower>0</soleVotingPower>
<sharedVotingPower>0</sharedVotingPower>
<soleDispositivePower>0</soleDispositivePower>
<sharedDispositivePower>0</sharedDispositivePower>
</reportingPersonBeneficiallyOwnedNumberOfShares>
<reportingPersonBeneficiallyOwnedAggregateNumberOfShares>0</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
<aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
<classPercent>0</classPercent>
<typeOfReportingPerson>IV</typeOfReportingPerson>
</coverPageHeaderReportingPersonDetails>
<items>
<item1>
<issuerName>InMed Pharmaceuticals Inc.</issuerName>
<issuerPrincipalExecutiveOfficeAddress>Suite 1445 - 885 W. Georgia Street, Vancouver, British Columbia, Canada, 00000</issuerPrincipalExecutiveOfficeAddress>
</item1>
<item2>
<filingPersonName>AdvisorShares Trust</filingPersonName>
<principalBusinessOfficeOrResidenceAddress>4800 Montgomery Lane, Suite 150&#13;
Bethesda, Maryland 20814</principalBusinessOfficeOrResidenceAddress>
<citizenship>Delaware</citizenship>
</item2>
<item3>
<notApplicableFlag>N</notApplicableFlag>
<typeOfPersonFiling>IV</typeOfPersonFiling>
</item3>
<item4>
<amountBeneficiallyOwned>0</amountBeneficiallyOwned>
<classPercent>0</classPercent>
<numberOfSharesPersonHas>
<solePowerOrDirectToVote>0</solePowerOrDirectToVote>
<sharedPowerOrDirectToVote>0</sharedPowerOrDirectToVote>
<solePowerOrDirectToDispose>0</solePowerOrDirectToDispose>
<sharedPowerOrDirectToDispose>0</sharedPowerOrDirectToDispose>
</numberOfSharesPersonHas>
</item4>
<item5>
<notApplicableFlag>N</notApplicableFlag>
<classOwnership5PercentOrLess>Y</classOwnership5PercentOrLess>
</item5>
<item10>
<notApplicableFlag>N</notApplicableFlag>
<certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.</certifications>
</item10>
</items>
<signatureInformation>
<reportingPersonName>AdvisorShares Trust</reportingPersonName>
<signatureDetails>
<signature>/s/ Stefanie Lititle</signature>
<title>Stefanie Little - Chief Compliance Officer</title>
<date>04/02/2025</date>
</signatureDetails>
</signatureInformation>
</formData>
</edgarSubmission>
